479 AGEN1181, an Fc-enhanced anti-CTLA-4 antibody, alone and in combination with balstilimab (anti-PD-1) in patients with advanced solid tumors: Initial phase I results

• Andrea Bullock,
• Justin Moser,
• Daruka Mahadevan,
• Michael Gordon,
• Przemyslaw Twardowski,
• Apostolia Tsimberidou,
• Breelyn Wilky,
• Waldo Ortuzar Feliu,
• Anthony El-Khoueiry,
• Steven O’Day,
• Bruno Bockorny,
• Katherine Rosenthal

Affiliations

Andrea Bullock

8Beth Israel Deaconess Hospital, boston, MA, USA

Justin Moser

Oncology, Huntsman Cancer Institute, Salt Lake City, Utah, USA

Daruka Mahadevan

Aff1 0000 0001 2168 186Xgrid.134563.6Department of Medicine Division of Hematology/OncologyUniversity of Arizona Cancer Center 1515. N. Campbell Avenue, Room 1905 85724 Tucson AZ USA

Michael Gordon

4HonorHealth Cancer Care Network, Scottsdale, AZ, USA

Przemyslaw Twardowski

Aff5 grid.410425.60000000404218357City of Hope Duarte CA USA

Apostolia Tsimberidou

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Breelyn Wilky

3University of Colorado Anschutz Medical, Aurora, CO, USA

Waldo Ortuzar Feliu

4Agenus inc, Lexington, Massachusetts, USA

Anthony El-Khoueiry

1University of Southern California, Los Angeles, CA, USA

Steven O’Day

4John Wayne Cancer Institute, Santa Monica, CA, USA

Bruno Bockorny

2Beth Israel Deaconess Medical Center, Boston, MA, USA

Katherine Rosenthal

8Agenus Inc, Lexington, USA